Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
NEJM AI|June 19, 2025
Longitudinal Risk Prediction for Pediatric Glioma with Temporal Deep LearningDivyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.Radiology. Artificial Intelligence|March 6, 2024
Noninvasive Molecular Subtyping of Pediatric Low-Grade Glioma with Self-Supervised Transfer LearningDivyanshu Tak, Zezhong Ye, Anna Zapaischykova, et al.Neuro-Oncology|April 3, 2020
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, et al.Journal of Neuropathology and Experimental Neurology|September 11, 2016
Hippocampal Formation Maldevelopment and Sudden Unexpected Death across the Pediatric Age SpectrumHannah C Kinney, Annapurna H Poduri, Jane B Cryan, et al.Neuro-Oncology|August 30, 2024
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomasMaryamalsadat Mahootiha, Divyanshu Tak, Zezhong Ye, et al.AJNR. American Journal of Neuroradiology|August 17, 2023
Dandy-Walker Phenotype with Brainstem Involvement: 2 Distinct Subgroups with Different PrognosisC A P F Alves, J Sidpra, A Manteghinejad, et al.Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.Pediatric Blood & Cancer|November 3, 2020
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade gliomaKaren D Wright, Xiaopan Yao, Wendy B London, et al.Radiology|September 28, 2021
Artificial Intelligence Algorithm Improves Radiologist Performance in Skeletal Age Assessment: A Prospective Multicenter Randomized Controlled TrialDavid K Eng, Nishith B Khandwala, Jin Long, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2022
Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panelsErin Rooney Riggs, Taylor I Bingaman, Carrie-Ann Barry, et al.Pageof 21